Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
Clicks: 205
ID: 116797
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
203 views
32 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract. Severe outcomes and death from the novel coronavirus disease 2019 (COVID-19) appear to be characterized by an exaggerated immune response with hyperc
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (22 words).
Try re-searching for a better abstract.
| Reference Key |
franck2020endocrinologyestradiol,
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mauvais-Jarvis, Franck;Klein, Sabra L;Levin, Ellis R; |
| Journal | endocrinology |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.